Gentisyl alcohol, an antioxidant from microbial metabolite, induces angiogenesis in vitro

Journal of Microbiology and Biotechnology

Volumn 16, Issue 3, 2006, Pages 475-479

  Kim, Hye Jin ^a,b   Kim, Jin Hee ^c   Lee, Choong Hwan ^c   Kwon, Ho Jeong ^a  

^a Yonsei University   (South Korea)

^b Sejong University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Angiogenesis; Antioxidant; Gentisyl alcohol; Tube formation

Indexed keywords

ANTIOXIDANT; GENTISYL ALCOHOL; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; BOVIDS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; HISTOGENESIS; IN VITRO STUDY; ISOLATION PROCEDURE; MICROBIAL METABOLISM; NONHUMAN; OXIDATIVE STRESS; PENICILLIUM; PHENOTYPE;

ANIMALIA; BOVIDAE; BOVINAE; PENICILLIUM; PENICILLIUM SP.;

EID: 33645549470     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alfaro, C., A. Urios, M. C. Gonzalez, P. Moya, and M. Blanco. 2003. Screening for metabolites from Penicillium novae-zeelandiae displaying radical-scavenging activity and oxidative mutagenicity: Isolation of gentisyl alcohol. Mutat. Res. 539: 187-194.
2. Folkman, J. 1995. Tumor angiogenesis in women with node-positive breast cancer. Cancer J. Sci. Am. 1: 106.
3. Hanahan, D. and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
4. Jung, H. J., H. B. Lee, C. J. Kim, J. Rho, R. J. Shin, and H. J. Kwon. 2003. Anti-angiogenic activity of Terpestacin, a bicyclo Sesterterpene from Embellisia chlamydospora. J. Antibiot. 56: 492-496.
5. Kim, J. H., D. H. Kim, M. R. Kim, H. J. Kwon, T. W. Oh, and C. H. Lee. 2005. Gentisyl alcohol inhibits apoptosis by suppressing of caspase activity induced by etoposide. J. Microbiol. Biotechnol. 15: 532-536.
6. Klagsbrun, M. and M. A. Moses. 1999. Molecular angiogenesis. Chem. Biol. 6: R217-R224.
7. Kwon, H. J., D. H. Kim, J. S. Shim, and J. W. Ahn. 2002. Apicularen A, macrolide from Chondromyces sp., inhibits growth factor induced in vitro angiogenesis. J. Microbiol. Biotechnol. 12: 702-705.
8. Kwon, H. J., J. H. Kim, H. J. Jung, Y. G. Kwon, M. Y. Kim, J. R. Rho, and J. Shin. 2001. Anti-angiogenic activity of acalycixenolide E, a novel marine natural product from Acalycigorgia inermis. J. Microbiol. Biotechnol. 11: 656-662.
9. Kwon, H. J., J. S. Shim, J. H. Kim, H. Y. Cho, Y. N. Yum, S. H. Kim, and J. H. Yu. 2002. Betulinic acid inhibits growth factor-induced in vivo angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn. J. Cancer Res. 93: 417-425.
10. Lakka, S. S., C. S. Gondi, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, and J. S. Rao. 2004. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689.
11. Lim, H., M. K. Kim, Y. H. Cho, J. M. Kim, Y. Lim, and C. H. Lee. 2004. Inhibition of cell cycle progression and induction of apoptosis in HeLa cells by HY-558-1, a novel CDK inhibitor isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 14: 978-984.
12. Maulik, N. and P. K. Das. 2002. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med 33: 1047-1060.
13. McNamara, D. A., J. H. Harmey, T. N. Walsh, H. P. Redmond, and D. J. Bouchier-Hayes. 1998. Significance of angiogenesis in cancer therapy Br. J. Surg. 85: 1044-1055.
14. Monte, M., L. E. Davel, and E. Sacerdote de Lustig. 1997. Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J. Cancer 33: 676-682.
15. Oh, S., M. Kim, J. J. Churey, and R. W. Worobo. 2003. Purification and characterization of an antilisterial bacteriocin produced by Leuconostoc sp. W65. J. Microbiol. Biotechnol. 13: 680-686.
16. Oliver, V. K., A. M. Patton, S. Desai, D. Lorang, S. K. Libutti, and E. C. Kohn. 2003. Regulation of the proangiogenic microenvironment by carboxyamido-triazole. J. Cell Physiol. 197: 139-148.
17. Rhee, K. H. 2003. Purification and identification of an antifungal agent from Streptomyces sp. KH-614 antagonistic to rice blast fungus, Pyricularia oryzae. J. Microbiol. Biotechnol. 13: 984-988.
18. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
19. Sata, M., H. Perlman, D. A. Muruve, M. Silver, M. Ikebe, T. A. Libermann, P. Oettgen, and K. Walsh. 1998. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. USA 95: 1213-1217.
20. Sato, Y. and D. B. Rifkin. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta-1-like molecule by plasmin during co-culture. J. Cell Biol. 109: 309-315.
21. Sohng, I. K., H. C. Lee, K. Liou, E. B. Lee, S. Y. Kang, and J. S. Woo. 2003. Cystocin, a novel antibiotic, produced by Streptomyces sp. GCA0001: Production and characterization of cystocin. J. Microbiol. Biotechnol. 13: 483-486.
22. Webster, K. A. 2003. Therapeutic angiogenesis: A complex problem requiring a sophisticated approach. Cardiovasc. Toxicol. 3: 283-298.